Anabolic steroids in sport and exercise:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Champaign, Ill. [u.a.]
Human Kinetics
2000
|
Ausgabe: | 2. ed. |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XVIII, 493 S. Ill., graph. Darst. |
ISBN: | 0880117869 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV013683863 | ||
003 | DE-604 | ||
005 | 20011002 | ||
007 | t | ||
008 | 010417s2000 ad|| |||| 00||| eng d | ||
020 | |a 0880117869 |9 0-88011-786-9 | ||
035 | |a (OCoLC)41885904 | ||
035 | |a (DE-599)BVBBV013683863 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-703 | ||
050 | 0 | |a RC1230 | |
082 | 0 | |a 362.29/088/796 |2 21 | |
084 | |a ZX 9420 |0 (DE-625)158516:14257 |2 rvk | ||
245 | 1 | 0 | |a Anabolic steroids in sport and exercise |c Charles E. Yesalis ed. |
250 | |a 2. ed. | ||
264 | 1 | |a Champaign, Ill. [u.a.] |b Human Kinetics |c 2000 | |
300 | |a XVIII, 493 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Anabolik Steroidler - Sağlık açısından | |
650 | 4 | |a Anabolisants - Aspect sanitaire | |
650 | 4 | |a Dopage dans les sports | |
650 | 4 | |a Sporda doping | |
650 | 4 | |a Anabolic Agents |x adverse effects | |
650 | 4 | |a Anabolic steroids |x Health aspects | |
650 | 4 | |a Doping in Sports | |
650 | 4 | |a Doping in sports | |
650 | 0 | 7 | |a Gesundheitsschaden |0 (DE-588)4157178-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Doping |0 (DE-588)4126002-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Nebenwirkung |0 (DE-588)4317914-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Gesundheitsgefährdung |0 (DE-588)4071808-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Anabolikum |0 (DE-588)4142319-7 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Doping |0 (DE-588)4126002-8 |D s |
689 | 0 | 1 | |a Gesundheitsgefährdung |0 (DE-588)4071808-6 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Anabolikum |0 (DE-588)4142319-7 |D s |
689 | 1 | 1 | |a Nebenwirkung |0 (DE-588)4317914-9 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Doping |0 (DE-588)4126002-8 |D s |
689 | 2 | 1 | |a Gesundheitsschaden |0 (DE-588)4157178-2 |D s |
689 | 2 | |8 1\p |5 DE-604 | |
700 | 1 | |a Yesalis, Charles E. |e Sonstige |4 oth | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009350474&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-009350474 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804128497495441408 |
---|---|
adam_text | Contents
Preface xi
Credits xvii
Introduction 1
PART I History and Incidence of Use 15
Chapter 1 Anabolic Androgenic Steroids:
A Historical Perspective and Definition 17
Charles D. Kochakian, PhD, and Charles E.Yesalis, ScD
Endocrine Function of the Testis 18
Androgens: Multiplicity of Male Hormones 21
Anabolic Activity 25
Partial Dissociation of Anabolic Activity From Androgenic Activity 26
Anabolic Steroids 30
Anabolic Androgenic Steroids 34
Therapeutic and Other Applications 35
Veterinary Applications 40
Summary 40
References 41
Chapter 2 History of Anabolic Steroid Use
in Sport and Exercise 51
Charles E.Yesalis,ScD; Stephen P.Courson;
and James E.Wright, PhD
Olympic Sports 54
Female Athletes 56
National Doping Programs 57
Professional Football 59
College 62
High School 64
Other Sports 65
Conclusions 66
References 66
Contents vii
Chapter 3 Incidence of Anabolic Steroid Use: A Discussion
of Methodological Issues 73
Charles E. Yesalis, ScD; Michael S. Bahrke, PhD; Andrea N.
Kopstein, PhD; and Camille K. Barsukiewicz, PhD
Investigative Journalism 74
Government Investigations 75
Drug Testing 76
Surveys 78
Current Trends 79
Methodological Issues 98
Validation 104
Recommendations 105
Summary 105
References 106
Chapter 4 Prevention of Anabolic Steroid Use 117
Linn Goldberg, MD, and Diane L. Elliot, MD
Scope of the Problem 118
Drug Testing Policy 119
Educational Strategies 121
AS Education:The ATLAS Study 122
The ATLAS Program 126
Conclusion 130
References 131
PART II Effects, Dependence,
and Treatment Issues 137
Chapter 5 Effect of Anabolic Steroid Use on Body
Composition and Physical Performance 139
Karl E.Friedl, PhD
Variations in Physiological Response to Anabolic Steroids 140
Comparing Anabolic Steroid Dose and Effects 141
Empirical Strength Studies 143
Composition of Steroid Induced Body Weight Gain 151
Body Composition Changes After Cessation of Anabolic Steroid Use 157
Neuromuscular and Neuropsychological Effects of Anabolic Steroid Use 158
Sustainment of Androgenicity During Demanding Physical Training 159
viii Contents
Countermeasures for Stress Induced Catabolic Hormones 161
Improved Aerobic Endurance Performance 163
Conclusions 164
References 165
Chapter 6 Effects of Anabolic Steroids
on Physical Health 175
Karl E.Friedl, PhD
Distinctions Between Types and Doses of Anabolic Steroids 177
Case Reports of Adverse Effects in Anabolic Steroid Using Athletes 178
Suspected Disease Associations 179
Stroke: A New Association With Anabolic Steroids 179
Prostate: An Androgen Target and Potential for Disease 183
Musculoskeletal Injuries 184
Problems Indirectly Associated With Anabolic Steroids 184
Research on Health Effects 185
Conclusions 206
References 208
Chapter 7 Women and Anabolic Steroids 225
Diane L. Elliot, MD and Linn Goldberg, MD
Normal Physiological Effects of Testosterone in Women and Men 226
Prevalence of Anabolic Steroid Use in Females 228
Physical Effects of Anabolic Steroids on Women 228
Psychological Effects of Anabolic Steroids on Females 233
DHEA: A Weak Androgen 235
Physique Altering Drug Use 236
Summary 239
References 239
Chapter 8 Psychological Effects of
Endogenous Testosterone
and Anabolic Androgenic Steroids 247
Michael S.Bahrke, PhD
Anabolic Steroids and Aggressive Behavior in Animals 249
Effect of Endogenous Testosterone Levels on Human Moods
and Behaviors 251
Estrogen Related Aggression 254
Male Contraceptive Studies and Moods 255
Effects of Anabolic Steroids on Athletes Moods and Behavior 256
Contents ix
Effects of Anabolic Steroids on Psychological Dependence and
Withdrawal 266
Methodological Issues 268
Conclusions 270
References 271
Chapter 9 Anabolic Steroids: Potential for Physical
and Psychological Dependence 279
KirkJ.Brower,MD
The Nature of Drug Abuse and Dependence 280
Evidence for Dependence on Anabolic Steroids 285
Mechanisms of Anabolic Steroid Dependence 289
Predictors of Anabolic Steroid Dependence 293
Course of Dependence on Anabolic Steroids 294
Prevention and Treatment 296
Summary 298
References 299
Chapter 10 Assessment and Treatment of Anabolic Steroid
Abuse, Dependence, and Withdrawal 305
Kirk J. Brower, MD
Identification and Assessment 306
Treatment of Withdrawal 314
Conclusions 327
References 327
Chapter 11 Legal Aspects of Anabolic Steroid
Use and Abuse 333
Carol Cole Kleinman, MD, JD, and C.E. Petit, JD
Direct Legal Consequences of Steroid Abuse 335
Indirect Legal Consequences of Steroid Abuse: Criminal Behavior 348
The Proper Role of the Legal System Regarding Steroid Abuse 353
Conclusion 354
References 355
PART III Drug Testing and Societal
Alternatives 361
Chapter 12 Evolution and Politics of Drug Testing 363
Jim Ferstle
x Contents
The Year of Scandals 364
History of Drug Testing 368
The Roots of Modern Drug Testing 371
Challenges and Limitations in Drug Testing 375
Causes for Criticism of Drug Testing 378
Possible Solutions Outside the IOC 383
Athletes Rights in Drug Testing 385
1984:The L.A. Cover Up 386
More Secrets 387
Testing Issues in Pro and U.S. Collegiate Sports 391
Politics and Pharmacological Warfare 392
Drug Testing and the Media 405
Conclusion 407
References 408
Chapter 13 Drug Testing and Anabolic Steroids 415
R.Craig Kammerer,PhD
Blood or Urine Testing? 417
Structures, Chemistry, and Metabolism 419
Technology of Anabolic Steroid Testing 429
Philosophy of Anabolic Steroid Testing 435
Costs of Anabolic Steroid Testing 437
Circumventing Positive Test Results 438
Use of Other Substances 441
Future Directions in Anabolic Steroid Testing 446
References 449
Chapter 14 Societal Alternatives 461
Charles E. Yesalis, ScD; Michael S. Bahrke, PhD;
and James E.Wright, PhD
Legalization: An End to Hypocrisy? 464
Interdiction: A Question of Cost Effectiveness 465
Education: Is Anybody Listening? 467
Conclusion: Our Values Must Change 470
References 472
Index 475
About the Editor 489
About the Contributors 491
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV013683863 |
callnumber-first | R - Medicine |
callnumber-label | RC1230 |
callnumber-raw | RC1230 |
callnumber-search | RC1230 |
callnumber-sort | RC 41230 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | ZX 9420 |
ctrlnum | (OCoLC)41885904 (DE-599)BVBBV013683863 |
dewey-full | 362.29/088/796 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 362 - Social problems and services to groups |
dewey-raw | 362.29/088/796 |
dewey-search | 362.29/088/796 |
dewey-sort | 3362.29 288 3796 |
dewey-tens | 360 - Social problems and services; associations |
discipline | Sport Soziologie |
edition | 2. ed. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02253nam a2200589 c 4500</leader><controlfield tag="001">BV013683863</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20011002 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">010417s2000 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0880117869</subfield><subfield code="9">0-88011-786-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)41885904</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013683863</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC1230</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.29/088/796</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">ZX 9420</subfield><subfield code="0">(DE-625)158516:14257</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anabolic steroids in sport and exercise</subfield><subfield code="c">Charles E. Yesalis ed.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Champaign, Ill. [u.a.]</subfield><subfield code="b">Human Kinetics</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 493 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anabolik Steroidler - Sağlık açısından</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anabolisants - Aspect sanitaire</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dopage dans les sports</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sporda doping</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anabolic Agents</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anabolic steroids</subfield><subfield code="x">Health aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Doping in Sports</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Doping in sports</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsschaden</subfield><subfield code="0">(DE-588)4157178-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Doping</subfield><subfield code="0">(DE-588)4126002-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nebenwirkung</subfield><subfield code="0">(DE-588)4317914-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsgefährdung</subfield><subfield code="0">(DE-588)4071808-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Anabolikum</subfield><subfield code="0">(DE-588)4142319-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Doping</subfield><subfield code="0">(DE-588)4126002-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitsgefährdung</subfield><subfield code="0">(DE-588)4071808-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Anabolikum</subfield><subfield code="0">(DE-588)4142319-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Nebenwirkung</subfield><subfield code="0">(DE-588)4317914-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Doping</subfield><subfield code="0">(DE-588)4126002-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Gesundheitsschaden</subfield><subfield code="0">(DE-588)4157178-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yesalis, Charles E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009350474&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009350474</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
id | DE-604.BV013683863 |
illustrated | Illustrated |
indexdate | 2024-07-09T18:50:11Z |
institution | BVB |
isbn | 0880117869 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009350474 |
oclc_num | 41885904 |
open_access_boolean | |
owner | DE-703 |
owner_facet | DE-703 |
physical | XVIII, 493 S. Ill., graph. Darst. |
publishDate | 2000 |
publishDateSearch | 2000 |
publishDateSort | 2000 |
publisher | Human Kinetics |
record_format | marc |
spelling | Anabolic steroids in sport and exercise Charles E. Yesalis ed. 2. ed. Champaign, Ill. [u.a.] Human Kinetics 2000 XVIII, 493 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Anabolik Steroidler - Sağlık açısından Anabolisants - Aspect sanitaire Dopage dans les sports Sporda doping Anabolic Agents adverse effects Anabolic steroids Health aspects Doping in Sports Doping in sports Gesundheitsschaden (DE-588)4157178-2 gnd rswk-swf Doping (DE-588)4126002-8 gnd rswk-swf Nebenwirkung (DE-588)4317914-9 gnd rswk-swf Gesundheitsgefährdung (DE-588)4071808-6 gnd rswk-swf Anabolikum (DE-588)4142319-7 gnd rswk-swf Doping (DE-588)4126002-8 s Gesundheitsgefährdung (DE-588)4071808-6 s DE-604 Anabolikum (DE-588)4142319-7 s Nebenwirkung (DE-588)4317914-9 s Gesundheitsschaden (DE-588)4157178-2 s 1\p DE-604 Yesalis, Charles E. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009350474&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Anabolic steroids in sport and exercise Anabolik Steroidler - Sağlık açısından Anabolisants - Aspect sanitaire Dopage dans les sports Sporda doping Anabolic Agents adverse effects Anabolic steroids Health aspects Doping in Sports Doping in sports Gesundheitsschaden (DE-588)4157178-2 gnd Doping (DE-588)4126002-8 gnd Nebenwirkung (DE-588)4317914-9 gnd Gesundheitsgefährdung (DE-588)4071808-6 gnd Anabolikum (DE-588)4142319-7 gnd |
subject_GND | (DE-588)4157178-2 (DE-588)4126002-8 (DE-588)4317914-9 (DE-588)4071808-6 (DE-588)4142319-7 |
title | Anabolic steroids in sport and exercise |
title_auth | Anabolic steroids in sport and exercise |
title_exact_search | Anabolic steroids in sport and exercise |
title_full | Anabolic steroids in sport and exercise Charles E. Yesalis ed. |
title_fullStr | Anabolic steroids in sport and exercise Charles E. Yesalis ed. |
title_full_unstemmed | Anabolic steroids in sport and exercise Charles E. Yesalis ed. |
title_short | Anabolic steroids in sport and exercise |
title_sort | anabolic steroids in sport and exercise |
topic | Anabolik Steroidler - Sağlık açısından Anabolisants - Aspect sanitaire Dopage dans les sports Sporda doping Anabolic Agents adverse effects Anabolic steroids Health aspects Doping in Sports Doping in sports Gesundheitsschaden (DE-588)4157178-2 gnd Doping (DE-588)4126002-8 gnd Nebenwirkung (DE-588)4317914-9 gnd Gesundheitsgefährdung (DE-588)4071808-6 gnd Anabolikum (DE-588)4142319-7 gnd |
topic_facet | Anabolik Steroidler - Sağlık açısından Anabolisants - Aspect sanitaire Dopage dans les sports Sporda doping Anabolic Agents adverse effects Anabolic steroids Health aspects Doping in Sports Doping in sports Gesundheitsschaden Doping Nebenwirkung Gesundheitsgefährdung Anabolikum |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009350474&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT yesalischarlese anabolicsteroidsinsportandexercise |